Abbott Laboratories
ABT
#93
Rank
$197.437 B
Marketcap
United States
Country
$114.10
Share price
3.99%
Change (1 day)
-24.85%
Change (1 year)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic…
Key Metrics
Trailing P/E
33.19
Forward P/E
16.91
EPS (TTM)
$3.09
Forward EPS
$6.07
Price / Book
3.47
EV / EBITDA
17.5x
Beta
0.59
Dividend Yield
2.47%
Return on Equity
10.58%
Return on Assets
5.33%
Debt / Equity
63.21
Current Ratio
1.38
Gross Margin
56.85%
Operating Margin
14.71%
Net Profit Margin
11.65%
Free Cash Flow
$7.209B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
-10.39%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$44.328B
Latest Net Income$6.524B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Abbott Laboratories with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
ABT
No recent news available. Set FINNHUB_API_KEY to enable news.
